search for books and compare prices
Paul A. Bunn has written 8 work(s)
Search for other authors with the same name
displaying 1 to 8 | at end
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9780824701321 Cover for 9780387543017 Cover for 9781841843018 Cover for 9781903734766 Cover for 9781841841151 Cover for 9781853179006 Cover for 9781841843025 Cover for 9781841843704
cover image for 9780824701321
Product Description: These questions and more, are answered by a distinguished team of nearly 40 specialists in the field who present the latest epidemiological, genetic, molecular, cellular, and diagnostic research findings in lung cancer research and their applications in patient management...read more
By Paul A. Bunn (editor) and Madeleine A. Kane (editor)

Hardcover:

9780824701321 | Ill edition (CRC Pr I Llc, September 1, 1998), cover price $199.95 | About this edition: These questions and more, are answered by a distinguished team of nearly 40 specialists in the field who present the latest epidemiological, genetic, molecular, cellular, and diagnostic research findings in lung cancer research and their applications in patient management.

cover image for 9780387543017
Product Description: The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary...read more

Hardcover:

9780387543017 | Springer Verlag, October 1, 1991, cover price $56.95 | About this edition: The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer.
9783540543015 | Gardners Books, September 1, 1991, cover price $111.15

cover image for 9781841843018
Product Description: With increasing emphasis being placed on screening and early prevention in cancer, this textbook examines the various methods and interventions used in screening in lung cancer, and presents a detailed review of the approaches to prevention and treatment of early disease...read more
By Paul A. Bunn (editor), Fred R. Hirsch, Ph. D. (editor) and Harubumi Kato (editor)

Hardcover:

9781841843018 | CRC Pr I Llc, January 1, 2006, cover price $329.95 | About this edition: With increasing emphasis being placed on screening and early prevention in cancer, this textbook examines the various methods and interventions used in screening in lung cancer, and presents a detailed review of the approaches to prevention and treatment of early disease.

cover image for 9781903734766
Product Description: More people die in the developed world from lung cancer than breast, prostate and colorectal cancer combined. Useful for primary healthcare physicians, this text provides information on the surgical and non surgical therapeutic strategies.

Paperback:

9781903734766 | 1 edition (Health Pr, December 30, 2010), cover price $25.00 | About this edition: More people die in the developed world from lung cancer than breast, prostate and colorectal cancer combined.

cover image for 9781841841151
Product Description: Lung Cancer Therapy Annual outlines key aspects in early diagnosis, classification and staging, and reviews in depth the current literature, discussing the latest developments in treatment and summarizing the most recent data in the field of chemotherapy and biologic therapy. (view table of contents, read Amazon.com's description)

Paperback:

9781841841151 | 2 edition (CRC Pr I Llc, January 1, 2002), cover price $100.00 | About this edition: Lung Cancer Therapy Annual outlines key aspects in early diagnosis, classification and staging, and reviews in depth the current literature, discussing the latest developments in treatment and summarizing the most recent data in the field of chemotherapy and biologic therapy.

cover image for 9781853179006
Product Description: The purpose of this publication is to inform all those involved in the treatment of lung cancer of the latest developments in its treatment during 1999. It summarizes the latest data in the field of chemotherapy of lung cancer - small cell carcinoma, non-small cell carcinoma and mesothelioma - given alone or in combination with radiotherapy or surgery...read more (view table of contents, read Amazon.com's description)

Paperback:

9781853179006 | CRC Pr I Llc, December 1, 2001, cover price $100.00 | About this edition: The purpose of this publication is to inform all those involved in the treatment of lung cancer of the latest developments in its treatment during 1999.

cover image for 9781841843025
Product Description: The global picture of lung cancer is undergoing major changes, with steady decrease in the incidence among men, an increase among women in the western countries, and a rapid rise among both sexes in the rest of the world. The treatment of lung cancer is also undergoing changes, with more optimistic therapeutic approaches that combine the major three treatment modalities: surgery, chemotherapy and radiotherapy, applied either concurrently or sequentially...read more

Hardcover:

9781841843025 | CRC Pr I Llc, August 1, 2003, cover price $79.95 | About this edition: The global picture of lung cancer is undergoing major changes, with steady decrease in the incidence among men, an increase among women in the western countries, and a rapid rise among both sexes in the rest of the world.

cover image for 9781841843704
Product Description: Briefing the oncology community about the most recent developments in lung cancer therapy, Lung Cancer Annual 4 provides a review of the related literature from the last year, and delivers an update of the impact that this information will have on the day-to-day management of lung cancer patients...read more

Hardcover:

9781841843704 | CRC Pr I Llc, May 10, 2005, cover price $99.95 | About this edition: Briefing the oncology community about the most recent developments in lung cancer therapy, Lung Cancer Annual 4 provides a review of the related literature from the last year, and delivers an update of the impact that this information will have on the day-to-day management of lung cancer patients.

displaying 1 to 8 | at end